← Back to All Stocks
Brainstorm Cell Therapeutics Inc. (BCLI) Analysis
Generated on: 2025-06-23 13:40:28 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 6,277,349 shares
Analysis Values
Current Price
$1.17
Predicted Price
$1.49
Expected Return
16.18%
Confidence Score
0.81
RSI (14)
57.14
MACD
0.01
Volume
38,353
Float Shares
6,277,349
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
250
BCLI
Brainstorm Cell Therapeutics Inc.
16.18%
Price: $1.17
Confidence: 0.81
News
Low Float
Last updated: 2025-06-23 13:40:28
Technical Analysis
RSI: 57.14
MACD: 0.01
Risk Analysis
Volatility
98.41%
Max Drawdown
-87.94%
Beta
1.0
Risk Score
94.5
Social Sentiment
0
Social Sentiment Score (0-100)
Recent News
BrainStorm Cell Therapeutics and Minaris partner on manufacturing NurOwn for trial
Clinical Trials Arena - 2025-05-28 09:36
BrainStorm said the partnership enhances its domestic manufacturing capabilities.
Reddit Discussions
No recent Reddit discussions found.
Recent SEC Filings
No recent SEC filings found.
